3 HealthTech Stocks up over 61% past 10 days (AVRO, DMAC, ENVB stock)
Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 61% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Avrobio, AVRO
Summary: Avrobio, Inc. is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc. is based in MA, United States.
Recent AVRO Stock Price (approx 10:00am EST.): $1.32
Previous Close for AVRO Stock: $1.31
Percentage Price Change Past 10 Days for AVRO stock: +89%
TipRanks.com reports that Avrobio stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for AVRO stock with an average price target is $3.75.
Click here to get the full story on AVRO stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.
Recent DMAC Stock Price (approx 10:00am EST.): $2.75
Previous Close for DMAC Stock: $2.84
Percentage Price Change Past 10 Days for DMAC stock: +74%
TipRanks.com reports that Diamedica Therapeutics stock currently has a Moderate Buy rating for DMAC.
Click here to get the full story on DMAC stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.
Recent ENVB Stock Price (approx 10:00am EST.): $6.10
Previous Close for ENVB Stock: $3.15
Percentage Price Change Past 10 Days for ENVB stock: +61%
Click here to get the full story on ENVB stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.